• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [16962 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2017     HAYES, Inc. Topical oxygen therapy for chronic wound healing
2017     HAYES, Inc. Transcranial direct current stimulation for depression
2017     NIHR Health Technology Assessment programme Seal or Varnish? A randomised controlled trial to determine the relative cost and effectiveness of pit and fissure sealant and fluoride varnish in preventing dental decay
2017     NIHR Health Technology Assessment programme Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis
2017     HAYES, Inc. Zepatier (Grazoprevir and Elbasvir) for chronic hepatitis C infection
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Axitinib (renal cell carcinoma) - benefit assessment according to §35a Social Code Book V (expiry of the decision)]
2017     NIHR Health Technology Assessment programme Clinical effectiveness, cost-effectiveness and acceptability of low-intensity interventions in the management of obsessive compulsive disorder: the Obsessive Compulsive Treatment Efficacy randomised controlled Trial (OCTET)
2017     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Intravitreal injections. Effectiveness and safety based on the place of the procedure]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Baricitinib (rheumatoid arthritis) - benefit assessment according to §35a Social Code Book V]
2017     NIHR Health Technology Assessment programme A pragmatic multicentre randomised controlled trial comparing stapled haemorrhoidopexy with traditional excisional surgery for haemorrhoidal disease: the eTHoS study
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Dolutegravir (HIV infection) - benefit assessment according to §35a Social Code Book V]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Optical coherence tomography (OCT) for neovascular age-related macular degeneration as well as diabetic retinopathy with macular oedema]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Reslizumab (asthma) - addendum to Commission A17-02]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for malignant neoplasms of the liver and intrahepatic bile ducts – addendum to commission H16-02D]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for uterine fibroids – addendum to commission H16-02B]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Systemic therapy in adults as a psychotherapeutic approach]
2017     NIHR Health Technology Assessment programme What carcinoembryonic antigen level should trigger further investigation during colorectal cancer follow-up? A systematic review and secondary analysis of a randomised controlled trial
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tenofovir alafenamide (chronic hepatitis B) – benefit assessment according to §35a Social Code Book V ]
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Prostate artery embolisation for benign prostatic hyperplasia
2017     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) Assistive technology – digital tools that involve social stimulation for mental health in later life
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Ipilimumab (Yervoy®) in the adjuvant therapy for high-risk stage III cutaneous melanoma
2017     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Treatment and evaluation methods used in forensic psychiatry]
2017     NIHR Health Technology Assessment programme Evaluation of the effectiveness and cost-effectiveness of lightweight fibreglass heel casts in the management of ulcers of the heel in diabetes: a randomised controlled trial
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Atezolizumab (Tecentriq®) in previously treated non-small cell lung cancer (NSCLC)
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Ceritinib (Zykadia®) as first-line therapy for patients with advanced ALK-positive non-small cell lung cancer
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Pembrolizumab (Keytruda®) as second-line treatment for patients with advanced urothelial carcinoma (UC)
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Percutaneous disc volume reduction with focus on chemonucleolysis. Update 2017
2017     NIHR Health Technology Assessment programme Barriers to and facilitators of smoking cessation in pregnancy and following childbirth: literature review and qualitative study
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Leadless pacemakers for right ventricle pacing. Update 2017
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Electric stimulation therapy (EST) in patients with gastroesophageal reflux disease
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Extracorporeal cytokine haemadsorption in patients with sepsis or SIRS
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Repetitive transcranial magnetic stimulation for treatment-resistant major depression
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Radiofrequency ablation for metastatic spinal lesions
2017     Health Quality Ontario (HQO) Hyperbaric oxygen therapy for the treatment of diabetic foot ulcers: a health technology assessment
2017     Institute of Health Economics (IHE) Endovascular therapy for acute ischemic stroke
2017     Health Quality Ontario (HQO) Prolaris cell cycle progression test for localized prostate cancer: a health technology assessment
2017     Institute of Health Economics (IHE) Community paramedicine: Program characteristics and evaluation
2017     Health Quality Ontario (HQO) Prostate cancer patient perspectives on the use of information in treatment decision-making: a systematic review and qualitative meta-synthesis
2017     Health Quality Ontario (HQO) Effect of early follow-up after hospital discharge on outcomes in patients with heart failure or chronic obstructive pulmonary disease: a systematic review
2017     Institute of Health Economics (IHE) The impacts of public reporting and external benchmarking in cardiac care: A rapid update of the literature
2017     Health Quality Ontario (HQO) Left atrial appendage closure device with delivery system: a health technology assessment
2017     Health Quality Ontario (HQO) Lumbosacral dorsal rhizotomy for spastic cerebral palsy: a health technology assessment
2017     Institute of Health Economics (IHE) Exploratory brief on glucose monitoring technologies
2017     NIHR Health Technology Assessment programme The use of fibrin sealant during non-emergency surgery: a systematic review of evidence of benefits and harms
2017     Health Quality Ontario (HQO) Robotic surgical system for radical prostatectomy: a health technology assessment
2017     NIHR Health Technology Assessment programme Randomised controlled trial evaluating the effectiveness and cost-effectiveness of 'Families for Health', a family-based childhood obesity treatment intervention delivered in a community setting for ages 6 to 11 years
2017     Health Quality Ontario (HQO) Percutaneous ventricular assist devices: OHTAC recommendation
2017     Health Quality Ontario (HQO) Hyperbaric oxygen therapy for the treatment of diabetic foot ulcers: OHTAC recommendation
2017     Agency for Healthcare Research and Quality (AHRQ) Supplemental project to assess the transparency of reporting for strategies to improve mental health care for children and adolescents
2017     Health Quality Ontario (HQO) Prolaris cell cycle progression test for localized prostate cancer: OHTAC Recommendation
2017     Agency for Healthcare Research and Quality (AHRQ) Strategies to improve mental health care for children and adolescents
2017     Health Quality Ontario (HQO) Left atrial appendage closure device with delivery system: OHTAC recommendation
2017     NIHR Health Technology Assessment programme Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive behavioural therapy for depression
2017     Health Quality Ontario (HQO) Lumbosacral dorsal rhizotomy for spastic cerebral palsy: OHTAC recommendation
2017     Health Quality Ontario (HQO) Robotic surgical system for radical prostatectomy: OHTAC recommendation
2017     Belgian Health Care Knowledge Centre (KCE) Anticoagulants in non-valvular atrial fibrillation
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Etelcalcetide (secondary hyperparathyroidism) - benefit assessment according to §35a Social Code Book V]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Rolapitant (prevention of nausea and vomiting in chemotherapy) - benefit assessment according to §35a Social Code Book V]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Nivolumab (squamous cell carcinoma of the head and neck) - benefit assessment according to §35a Social Code Book V]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pembrolizumab (classical Hodgkin lymphoma) - benefit assessment according to §35a Social Code Book V]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Secukinumab (plaque psoriasis) - addendum to Commission A17-08]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ixekizumab (plaque psoriasis) - addendum to Commission A17-07]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Osimertinib (NSCLC) - benefit assessment according to §35a Social Code Book V]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Alectinib (NSCLC) - benefit assessment according to §35a Social Code Book V]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tofacitinib (rheumatoid arthritis) - benefit assessment according to §35a Social Code Book V]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Dabrafenib (non-small cell lung cancer) - benefit assessment according to §35a Social Code Book V]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Trametinib (non-small cell lung cancer) - enefit assessment according to §35a Social Code Book V]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pembrolizumab (non-small cell lung cancer) - addendum to Commission A17-06]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Magnetic resonance imaging-guided high-intensity focused ultrasound therapy for uterine fibroids]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Magnetic resonance imaging-guided high-intensity focused ultrasound therapy for uterine fibroids]
2017     NIHR Health Technology Assessment programme Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis
2017     HAYES, Inc. Antibiotic-impregnated bone cement for total hip arthroplasty and other orthopedic indications
2017     HAYES, Inc. Arthroscopic hip surgery for femoroacetabular impingement
2017     HAYES, Inc. Comparative effectiveness of fiberoptic phototherapy for hyperbilirubinemia in term infants
2017     Center for Evidence-based Practice (CEP) Communicating with patients about pain management for acute on chronic pain
2017     NIHR Health Technology Assessment programme A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent
2017     NIHR Health Technology Assessment programme Is whole-colon investigation by colonoscopy, computerised tomography colonography or barium enema necessary for all patients with colorectal cancer symptoms, and for which patients would flexible sigmoidoscopy suffice? A retrospective cohort study
2017     HAYES, Inc. Comparative effectiveness review of cryoablation for primary treatment of localized prostate cancer
2017     Center for Evidence-based Practice (CEP) Medications for critical care patients with alcohol withdrawal
2017     HAYES, Inc. Comparative effectiveness review of dry needling for indications other than neck or trapezius muscle pain in adults
2017     Center for Evidence-based Practice (CEP) Strategies for transitioning adult medical-surgical inpatients with a need for mental health services to outpatient settings
2017     HAYES, Inc. Comparative effectiveness review of mosaicplasty for treatment of articular cartilage injuries
2017     Center for Evidence-based Practice (CEP) Preparation and patient education prior to colonoscopy
2017     HAYES, Inc. Fecal calprotectin assay for monitoring postoperative recurrence of Crohn disease
2017     Center for Evidence-based Practice (CEP) Needleless connectors for intravenous injections
2017     HAYES, Inc. Hydrogen breath test in patients with functional bowel disorders and suspected carbohydrate malabsorption
2017     Center for Evidence-based Practice (CEP) Pathways for management of alcohol withdrawal in critical care units
2017     HAYES, Inc. Hydrogen breath tests for diagnosis of small intestinal bacterial overgrowth in functional bowel disorders
2017     Center for Evidence-based Practice (CEP) Non-pharmacologic strategies for the management of inpatient aggressive behavior
2017     NIHR Health Technology Assessment programme The Asymptomatic Carotid Surgery Trial-2 (ACST-2): an ongoing randomised controlled trial comparing carotid endarterectomy with carotid artery stenting to prevent stroke
2017     NIHR Health Technology Assessment programme Youth social behaviour and network therapy (Y-SBNT): adaptation of a family and social network intervention for young people who misuse alcohol and drugs a randomised controlled feasibility trial
2017     HAYES, Inc. Intravenous lidocaine infusion for neuropathic pain: a review of reviews
2017     Center for Evidence-based Practice (CEP) Hypertension in patients undergoing carotid endarterectomy
2017     HAYES, Inc. Laparoscopic electromechanical morcellation of uterine fibroids during myomectomy orhysterectomy
2017     Center for Evidence-based Practice (CEP) Patient lifestyle education for lung transplant recipients
2017     NIHR Health Technology Assessment programme A pilot randomised controlled trial of community-led ANtipsychotic Drug REduction for Adults with Learning Disabilities
2017     HAYES, Inc. Positron Emission Tomography (PET) for Alzheimer disease
2017     Center for Evidence-based Practice (CEP) Heparin flush for central and peripheral venous access devices
2017     NIHR Health Technology Assessment programme Subcutaneous Injection of Adalimumab Trial compared with Control (SCIATiC): a randomised controlled trial of adalimumab injection compared with placebo for patients receiving physiotherapy treatment for sciatica
2017     HAYES, Inc. Radiofrequency ablation for sacroiliac joint denervation for chronic low back pain